Vimarsana
Biggest News Aggregation in the World

Novel Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Novel Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Novel Study Today - Breaking & Trending Today

MolecuLight Inc.: MolecuLight's Pioneering Fluorescence Imaging Technology Showcased in Prestigious Burns Journal in Novel Study - Vimarsana News

MolecuLight Inc.: MolecuLight's Pioneering Fluorescence Imaging Technology Showcased in Prestigious Burns Journal in Novel Study

TORONTO, May 30, 2024 /PRNewswire/ -- MolecuLight Inc., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria in wound care, celebrates the publication

Here's How One Company Is Training Fungi To Transform Waste - Vimarsana News

Here's How One Company Is Training Fungi To Transform Waste

A Chicago-based science tech company, Mycocycle, has turned to nature to manage waste and is training fungi to break down and detoxify construction materials.

Source: forbes.com
Understanding Familial Exudative Vitreoretinopathy - Vimarsana News

Understanding Familial Exudative Vitreoretinopathy

Familial exudative vitreoretinopathy (FEVR) is a rare genetic disorder that affects the development of the blood vessels in the retina.

Source: forbes.com
For people with autism navigating public transit, virtual reality help could be on the way - Vimarsana News

For people with autism navigating public transit, virtual reality help could be on the way

Research from the University of Missouri and the University of Georgia looked at the different experiences for people with autism at a bus stop.

Source: yahoo.com
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at Upcoming Scientific Meetings - Vimarsana News

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at Upcoming Scientific Meetings

Results from the EXPEDITE study of Remodulin® induction prior to Orenitram® therapy to be presented at ATS Baseline patient data from the TETON studies of Tyvaso® Inhalation Solution in... | April 18, 2023